KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Account Payables (2016 - 2025)

Medpace Holdings' Change in Account Payables history spans 11 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 1982.81% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $2.6 million, up 188.67%, while the annual FY2025 figure was $2.6 million, 188.67% up from the prior year.
  • Change in Account Payables reached $1.3 million in Q4 2025 per MEDP's latest filing, up from -$10.7 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $10.7 million in Q1 2025 to a low of -$10.7 million in Q3 2025.
  • Average Change in Account Payables over 5 years is $450600.0, with a median of $682500.0 recorded in 2024.
  • Peak YoY movement for Change in Account Payables: soared 2093.31% in 2022, then plummeted 1761.98% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$284000.0 in 2021, then skyrocketed by 2093.31% to $5.7 million in 2022, then plummeted by 65.17% to $2.0 million in 2023, then tumbled by 96.75% to $64000.0 in 2024, then skyrocketed by 1982.81% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Change in Account Payables are $1.3 million (Q4 2025), -$10.7 million (Q3 2025), and $1.3 million (Q2 2025).